… treatment for patients with coronary artery disease (CAD). Defining the optimal DAPT regimen
in patients undergoing … bleeding, such as Asian patients [1,2,3]. Before the introduction of …

… treatments for coronary artery disease. Atrial fibrillation (AF) is the most common complication
after CABG… Gal3 belongs to the lectin family and is a potent inflammatory protein. Gal-3 can …

… (PCI) and coronary artery bypass grafting (CABG), have … 2021 USA Long-term follow-up
of patients undergoing non-… remarkable strides, boasting potent antiplatelet agents, lipid-…

… of aspirin and the potent oral P2Y12 inhibitor ticagrelor has … vein graft failure in patients
undergoing coronary artery bypass … that enrolled patients with stable coronary artery disease or …

… Prasugrel and ticagrelor, 2 newer, more potent P2Y12 … findings, the subgroup of patients
undergoing CABG in the TRITON-… cannot rule out psychological factors affecting the decision for …

… grafting (CABG) is one of the treatment options for CAD. The … coronary artery with an
autologous graft (arterial or venous) … are potent regulators of apoptosis, releasing apoptotic factors …

… The rates of ischemic and bleeding events were comparable in patients undergoing CABG
… potent agent, especially if there is a possibility of subsequent urgent or emergent need for …

… 20 male patients with heart failure who had undergone … the patients with CAD compared to
the healthy individuals, and … in this regard further confirms the potency of the study outcomes. …

… A total of 181 subjects with stable coronary artery disease (CAD), who underwent CABG …
The power of TTFM to predict the potency of grafts in the long term is still controversial. A …

… post coronary artery bypass grafting surgery (CABG), that … post-CABG strokes and develop
post-CABG management. In this … operative stroke in patients who underwent CABG and had a …